PAR 4.55% 23.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA, page-40

  1. 485 Posts.
    lightbulb Created with Sketch. 48
    Fabulous result and a major step forward on the FDA journey. Indeed it’s a massive understatement to say that the next 18 months are going to be a interesting ride for PAR as big Pharma position themselves. Well done to all involved in achieving this major milestone on the roller coaster that is pharmaceutical commercialisation.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
0.010(4.55%)
Mkt cap ! $80.45M
Open High Low Value Volume
22.8¢ 23.3¢ 22.5¢ $46.92K 203.9K

Buyers (Bids)

No. Vol. Price($)
1 337 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 138166 5
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.